Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 396

Results For "CENT"

4418 News Found

Zydus Cadila submits NDA to Drug Controller General of India for Chronic Kidney Disease
Biotech | November 23, 2021

Zydus Cadila submits NDA to Drug Controller General of India for Chronic Kidney Disease

The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis


Philips integrates MedChat’s AI to optimise automated patient communication
Digitisation | November 23, 2021

Philips integrates MedChat’s AI to optimise automated patient communication

Hospitals and outpatient clinics can also digitally navigate patients from the time an order is placed, to when it is scheduled and completed through follow-up


Molbio has pioneered point of care molecular testing: Sriram Natarajan
interviews | November 22, 2021

Molbio has pioneered point of care molecular testing: Sriram Natarajan

Molbio Diagnostics has been the pioneer in providing access to molecular testing through its Truenat Real Time PCR platform. Sriram Natarajan, Director & CEO, of the company shares his experiences on the journey so far in an interview with Thomas C Thottathil


HCG acquires Suchirayu Healthcare Solutions
Hospitals | November 22, 2021

HCG acquires Suchirayu Healthcare Solutions

Suchirayu owns a state-of-the-art multi-speciality hospital in Hubli with an operational capacity of 110 beds and a potential to scale up to 250 beds


Merck showcases potential for several cancers, MS and lupus
News | November 22, 2021

Merck showcases potential for several cancers, MS and lupus

Five potential first-in-class assets aimed at delivering significant long-term growth. Over 14 clinical development programs underway across portfolio and 11 new studies to start in 2022 across early- and late-stage pipeline


Funding push to pharma R&D critical for unleashing next phase of growth
News | November 20, 2021

Funding push to pharma R&D critical for unleashing next phase of growth

The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation


U.S. FDA approves first drug to improve growth in kids with most common form of dwarfism
Drug Approval | November 20, 2021

U.S. FDA approves first drug to improve growth in kids with most common form of dwarfism

Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth


Sahyadri Hospital, Karad conducted the first taluka level liver transplant
Hospitals | November 19, 2021

Sahyadri Hospital, Karad conducted the first taluka level liver transplant

Taluka level transplant centre will add convenience to patients from rural areas


CIMS multi super specialty hospital performs 150 bone marrow transplants
Public Health | November 19, 2021

CIMS multi super specialty hospital performs 150 bone marrow transplants

The Ahmedabad based hospital in association with Sankalp India Foundation had established the BMT unit in 2017


PM Modi hails pharma industry for its innovation
News | November 19, 2021

PM Modi hails pharma industry for its innovation

Betting big on talent, resources, and the ecosystem required for innovation and enterprise, Prime Minister Narendra Modi invited stakeholders to ideate in India, innovate in India and Make in India for the world